Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Human Gene Therapy|May 27, 2023
Long Non-Coding RNAs, Cell Cycle, and Human Breast CancerQinan Yin, Haodi Ma, Gayan Bamunuarachchi, et al.Translational Oncology|September 16, 2022
Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targetsXuewei Zheng, Haodi Ma, Jingjing Wang, et al.Theranostics|March 9, 2026
Development of a dendritic cell-targeted vaccine strategy using proximity-induced conjugationZhidong Wang, Xiaolin Yang, Jianjiang Li, et al.Journal of Nanobiotechnology|March 5, 2026
pH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancerHaodi Ma, Liying Zhang, Lulu Wang, et al.Medicine|February 2, 2024
PLAU and GREM1 are prognostic biomarkers for predicting immune response in lung adenocarcinomaDongliao Fu, Zhigang Hu, Haodi Ma, et al.Journal of Inflammation Research|June 17, 2024
Host Factors Modulate Virus-Induced IFN Production via Pattern Recognition ReceptorsJingjing Wang, Yirui Dong, Xuewei Zheng, et al.Antibiotics (Basel, Switzerland)|April 27, 2026
Antibiotic Mechanisms and Resistance: Molecular Insights and Therapeutic StrategiesHaodi Ma, Liying Zhang, Lulu Wang, et al.Carbohydrate Polymers|January 22, 2025
Quaternary ammonium chitosan-functionalized mesoporous silica nanoparticles: A promising targeted drug delivery system for the treatment of intracellular MRSA infectionJunfeng Liu, Liying Zhang, Haodi Ma, et al.Molecular and Cellular Endocrinology|June 27, 2024
Replenishment of TCA cycle intermediates and long-noncoding RNAs regulation in breast cancerXuewei Zheng, ShunShun Zhang, HaoDi Ma, et al.Frontiers in Bioscience (Landmark Edition)|August 29, 2024
High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast CancerJing Liang, Haodi Ma, Shunshun Zhang, et al.Pageof 2